Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on September 10, 2013, to provide an update on its financial guidance. During upcoming meetings with securities analysts and investors between September 10 and September 27, 2013, the company's officers planned to reaffirm their full-year 2013 net income per share guidance. This guidance was set at a minimum of $7.89 per diluted share. The company also provided details on adjustments affecting this guidance, notably net costs of $0.11 per share. Excluding these specific items, WellPoint reiterated its expectation for adjusted net income of at least $8.00 per diluted share for the full year 2013. The filing also includes a standard Safe Harbor statement, highlighting the risks and uncertainties associated with forward-looking statements. This statement cautions investors against placing undue reliance on these projections due to various factors that could cause actual results to differ materially from those expected, including regulatory changes, healthcare cost trends, integration risks from acquisitions (like AMERIGROUP), and competitive pressures.
Key Highlights
- 1Reaffirmed full-year 2013 net income per share guidance of at least $7.89.
- 2Maintained expectation for adjusted net income per share of at least $8.00 for full-year 2013, excluding certain net costs.
- 3Specified net costs of $0.11 per share impacting the reported net income guidance.
- 4Detailed net adjustment items for 2013 guidance, including debt retirement expenses, tax benefits, acquisition costs, and investment gains/losses from the first half of the year.
- 5The company's officers were scheduled to discuss this guidance with analysts and investors from September 10 to September 27, 2013.
- 6Included a standard Safe Harbor statement warning about the risks and uncertainties of forward-looking statements.
- 7Mentioned the AMERIGROUP Corporation acquisition as a factor with integration risks and potential impacts on future performance.